Vaccinogen Completes Initial Closing of an $80 Million Financing
DigitalJournal.com At this first closing, Vaccinogen issued units of common stock and warrants priced at $5.50 per unit consisting of 1,869,159 shares of common stock and warrants to purchase 545,454 shares of common stock at an exercise price of $6.05 per share. |